Publications by authors named "Robert Gerbing"

Claim this Profile
C
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.
Andrew J Menssen, Chad A Hudson, Todd Alonzo, Robert Gerbing, Laura Pardo

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study.
Juliette Renaud, Bianca F Goemans, Franco Locatelli, Martina Pigazzi, Shelagh Redmond, Robert B Gerbing

Pediatr Blood Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.
Romy E van Weelderen, Christine J Harrison, Kim Klein, Yilin Jiang, Jonas Abrahamsson, Robert B Gerbing

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.
Kasey J Leger, Michael J Absalon, Biniyam G Demissei, Amanda M Smith, Robert B Gerbing

Front Cardiovasc Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Oussama Abla, Rhonda E Ries, Tim Triche, Robert B Gerbing, Betsy Hirsch

Blood Adv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, Stefan E Hubner, Robin L Go, Robert B Gerbing

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy.
Kasey J Leger, Nora Robison, Hari K Narayan, Amanda M Smith, Tenaadam Tsega, Robert B Gerbing

Front Cardiovasc Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
Fieke W Hoff, Yihua Qiu, Brandon D Brown, Robert B Gerbing, Amanda R Leonti

Proteomics Clin Appl· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Sara Zarnegar-Lumley, Todd A Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood -Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.
Romy E van Weelderen, Kim Klein, Christine J Harrison, Yilin Jiang, Jonas Abrahamsson, Robert B Gerbing

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CREBBP alterations are associated with a poor prognosis in de novo AML.
Adam J Lamble, Kohei Hagiwara, Robert B Gerbing, Jenny L Smith, Pandurang Kolekar

Blood· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
Alexandra M Stevens, Terzah M Horton, Chana L Glasser, Robert B Gerbing, Richard Aplenc

Pediatr Hematol Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of proteomic profiling in pediatric acute myeloid leukemia: a Children's Oncology Group study.
Fieke W Hoff, Anneke D Van Dijk, Yihua Qiu, Chenyue W Hu, Rhonda E Ries, Robert B Gerbing

Haematologica· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Tamara P Miller, Kelly D Getz, Yimei Li, Biniyam G Demissei, Peter C Adamson, Robert Gerbing

Lancet Haematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
Benjamin J Huang, Jenny L Smith, Jason E Farrar, Yi-Cheng Wang, Masayuki Umeda, Robert B Gerbing

Nat Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Ascertainment of Typhlitis From the Electronic Health Record.
Tamara P Miller, Yimei Li, Aaron J Masino, Emma Vallee, Evanette Burrows, Robert Gerbing

JCO Clin Cancer Inform· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, Patrick Brown, Elizabeth Fox

J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA.
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, Robert B Gerbing, Alan S Gamis

Proteomics Clin Appl· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Kelly D Getz, Todd A Alonzo, Lillian Sung, Soheil Meshinchi, Robert B Gerbing

Pediatr Blood Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
Matthew A Kutny, Todd A Alonzo, Oussama Abla, Madhvi Rajpurkar, Robert B Gerbing

JAMA Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival.
Lauren Pommert, Todd M Cooper, Robert B Gerbing, Lisa Brodersen, Michael Loken

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial.
Johann Hitzler, Todd Alonzo, Robert Gerbing, Amy Beckman, Betsy Hirsch

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes.
Benjamin J Huang, Jenny L Smith, Yi-Cheng Wang, Kassra Taghizadeh, Amanda R Leonti, Robert Gerbing

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Caitlin W Elgarten, Andrew C Wood, Yimei Li, Todd A Alonzo, Lisa Eidenschink Brodersen, Robert B Gerbing

Pediatr Blood Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis